BE822616A - Derives de 7alpha-methoxycephalosporine leur procede de preparation et leur application therapeutique - Google Patents

Derives de 7alpha-methoxycephalosporine leur procede de preparation et leur application therapeutique

Info

Publication number
BE822616A
BE822616A BE150876A BE150876A BE822616A BE 822616 A BE822616 A BE 822616A BE 150876 A BE150876 A BE 150876A BE 150876 A BE150876 A BE 150876A BE 822616 A BE822616 A BE 822616A
Authority
BE
Belgium
Prior art keywords
7alpha
preparation process
therapeutic application
methoxycephalosporin derivatives
methoxycephalosporin
Prior art date
Application number
BE150876A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP13244273A external-priority patent/JPS5624676B2/ja
Priority claimed from JP13244173A external-priority patent/JPS5417755B2/ja
Priority claimed from JP14209773A external-priority patent/JPS5442999B2/ja
Priority claimed from JP9212974A external-priority patent/JPS5123285A/ja
Priority claimed from JP9213174A external-priority patent/JPS5123286A/ja
Application filed filed Critical
Publication of BE822616A publication Critical patent/BE822616A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12Oxygen atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BE150876A 1973-11-26 1974-11-26 Derives de 7alpha-methoxycephalosporine leur procede de preparation et leur application therapeutique BE822616A (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP13244273A JPS5624676B2 (fr) 1973-11-26 1973-11-26
JP13244173A JPS5417755B2 (fr) 1973-11-26 1973-11-26
JP14209773A JPS5442999B2 (fr) 1973-12-18 1973-12-18
JP9212974A JPS5123285A (en) 1974-08-12 1974-08-12 77 metokishisefuarosuhorinjudotaino seiho
JP9213174A JPS5123286A (ja) 1974-08-12 1974-08-12 Sefuarosuhorinjudotaino seiho

Publications (1)

Publication Number Publication Date
BE822616A true BE822616A (fr) 1975-05-26

Family

ID=27525582

Family Applications (1)

Application Number Title Priority Date Filing Date
BE150876A BE822616A (fr) 1973-11-26 1974-11-26 Derives de 7alpha-methoxycephalosporine leur procede de preparation et leur application therapeutique

Country Status (14)

Country Link
US (1) US4007177A (fr)
BE (1) BE822616A (fr)
CA (1) CA1060432A (fr)
CH (1) CH611906A5 (fr)
DE (1) DE2455884C3 (fr)
DK (1) DK146538C (fr)
FR (1) FR2252100B1 (fr)
GB (1) GB1449420A (fr)
HU (1) HU169922B (fr)
IE (1) IE40220B1 (fr)
NL (3) NL172327C (fr)
NO (1) NO149281C (fr)
PH (1) PH14530A (fr)
SE (1) SE420201B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1348984A (en) * 1970-06-16 1974-03-27 Merck & Co Inc Antibiotics and processes for their production
JPS5641637B2 (fr) * 1973-11-26 1981-09-29
US4059578A (en) * 1974-09-09 1977-11-22 Smithkline Corporation 7-Substituted mercaptoacetamido cephamycins
US4101657A (en) * 1975-01-13 1978-07-18 Smithkline Corporation Cephamycins as antibacterial agents
US4126745A (en) 1975-04-30 1978-11-21 Sankyo Company Limited 7-Methoxycephalosporin derivatives
DE2539214C2 (de) * 1975-09-03 1984-03-29 E.R. Squibb & Sons, Inc., 08540 Princeton, N.J. 7-Methoxythienyl-ureido-cephalosporin und dieses enthaltendes Arzneimittel
IL50546A (en) * 1975-10-30 1980-07-31 Smithkline Corp 7-acyl-3-(1-(2-sulfaminoethyl)tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid derivatives and pharmaceutical compositions containing them
JPS6026800B2 (ja) * 1976-01-22 1985-06-25 富山化学工業株式会社 新規な7α−メトキシセフアロスポリン類およびその製造法
SE443143B (sv) * 1976-03-25 1986-02-17 Shionogi & Co Forfarande for framstellning av arylmalonamido-1-oxadetiacefalosporiner
US4053605A (en) * 1976-06-15 1977-10-11 Merck & Co., Inc. Esterified-2(3-lower-alkyl-amino-propoxy)-3-cyano-pyridines and derivatives
US4165429A (en) * 1976-06-28 1979-08-21 Yamanouchi Pharmaceutical Co., Ltd. 7α-METHOXY-CEPHALOSPORANIC ACID DERIVATIVES
JPS5331690A (en) * 1976-09-01 1978-03-25 Shionogi & Co Ltd Oxadithiacephalosporins
GB1579533A (en) * 1977-03-26 1980-11-19 Farmaceutici Italia Cephalosporins and their preparation
US4229573A (en) * 1977-06-21 1980-10-21 Asahi Kasei Kogyo Kabushiki Kaisha 7α-Methoxycephalosporin derivatives
JPS6052713B2 (ja) * 1978-04-11 1985-11-20 三共株式会社 7−メトキシセフアロスポリン化合物、その製法及びその化合物を主成分とする抗菌剤
JPS5583791A (en) * 1978-12-18 1980-06-24 Meiji Seika Kaisha Ltd 7-methoxycephalosporin derivative and its preparation
JPS59128392A (ja) * 1982-12-29 1984-07-24 Kureha Chem Ind Co Ltd セフアロスポリン誘導体及び該誘導体を含有する薬剤
JP5703009B2 (ja) * 2010-12-16 2015-04-15 住友精化株式会社 スルホン化合物、スルホン化合物の製造方法、および電気化学デバイス用電解液
CN104557978B (zh) * 2014-12-31 2017-07-18 重庆福安药业(集团)股份有限公司 一种头孢美唑钠的制备方法
EP3178643A1 (fr) 2015-12-10 2017-06-14 Danmarks Tekniske Universitet Procédé de fabrication d'une structure composite comprenant un ensemble de tissu textile
KR102188689B1 (ko) 2018-12-04 2020-12-09 (주)유케이케미팜 세프메타졸 소듐의 제조 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3530123A (en) * 1966-11-02 1970-09-22 Fujisawa Pharmaceutical Co 3-thiolated-7-sydnone-acylamino-cephalosporanic acid derivatives
GB1348984A (en) * 1970-06-16 1974-03-27 Merck & Co Inc Antibiotics and processes for their production
US3887549A (en) * 1971-11-19 1975-06-03 Merck & Co Inc Process for preparing 7-acylamido-7-methoxy-3-cephem-4-carboxylic acid, esters and salts
US3905963A (en) * 1972-01-25 1975-09-16 Lilly Co Eli Process for preparing primary 3-carbamoyloxymethyl cephalosporins
US3840531A (en) * 1972-03-21 1974-10-08 Lilly Co Eli Process for preparing 7-(alpha-hydroxy-alpha-phenyl)acetamido-3-(1-methyl-1h-tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid and derivatives thereof
US3920639A (en) * 1973-04-23 1975-11-18 Squibb & Sons Inc Cyanomethylthioacetyl-7-methoxycephalosporins
US3883520A (en) * 1973-08-17 1975-05-13 Smithkline Corp Substituted mercaptoacetamidocephalosporins

Also Published As

Publication number Publication date
DE2455884A1 (de) 1975-05-28
IE40220L (en) 1975-05-26
AU7573974A (en) 1976-05-27
DK611374A (fr) 1975-07-28
IE40220B1 (en) 1979-04-11
DK146538B (da) 1983-10-31
NL172327B (nl) 1983-03-16
NL8205005A (nl) 1983-04-05
PH14530A (en) 1981-08-31
DE2455884C3 (de) 1981-11-19
SE7414706L (fr) 1975-05-27
NO744222L (fr) 1975-06-23
HU169922B (fr) 1977-02-28
NO149281B (no) 1983-12-12
DE2455884B2 (de) 1981-01-22
NL7415432A (nl) 1975-05-28
CA1060432A (fr) 1979-08-14
FR2252100A1 (fr) 1975-06-20
GB1449420A (en) 1976-09-15
NL172327C (nl) 1983-08-16
NL8205006A (nl) 1983-04-05
CH611906A5 (fr) 1979-06-29
SE420201B (sv) 1981-09-21
NO149281C (no) 1984-03-21
FR2252100B1 (fr) 1978-07-28
DK146538C (da) 1984-04-09
US4007177A (en) 1977-02-08

Similar Documents

Publication Publication Date Title
FR2383157B1 (fr) Derives de chalcone, leur procede de preparation et leur application en therapeutique
BE794669A (fr) Derives de 3,4-dihydrocarbostyryle et leur procede de preparation
BE878723A (fr) Derives de 4-anilinoquinazoline, leur procede de preparation et leur application en therapeutique
BE822616A (fr) Derives de 7alpha-methoxycephalosporine leur procede de preparation et leur application therapeutique
BE823400A (fr) Derives de 2-acyl-4-oxo-pyrazino-isoquinoleine et leur procede de preparation
FR2312247A1 (fr) Derives de la thieno-pyridine, leur procede de preparation et leurs applications
BE823027A (fr) Derives d'isoquinoleine et leur procede de preparation
BE797245A (fr) Derives de 1,2,3-thiadiazole et leur procede de preparation
BE835224A (fr) Nouveaux derives piperidylideniques, leur procede de preparation et leur usage therapeutique
BE823973A (fr) Beta-aminoethylsilanes et leur procede de preparation
FR2296632A1 (fr) Derives de cyclopentane et leur procede de preparation
BE818055A (fr) Derives de dibenzoxepine et leur procede de preparation
BE798059A (fr) Derives de chromone et leur procede de preparation
FR2315925A1 (fr) Nouveaux derives de 5-benzyle-2-oxazolidone, leur procede de preparation et leur application en therapeutique
BE820385A (fr) D-homo-steroides et leur procede de preparation
FR2313063A1 (fr) Derives de pyrrolotriazolopyrimidine leur procede de preparation et leurs applications en therapeutique
BE790287A (fr) Acides pyrimidin-6yl acethydroxamiques, leur procede de preparation et leur application en therapeutique
LU79606A1 (fr) Derives de bisamidine,leur procede de preparation et leur application therapeutique
BE819321A (fr) Nouveaux 2,3-dihydrobenzofuranyl-7-n-methyl-carbamates n-sulfenyles, leur procede de preparation et leur application
BE832128A (fr) Derives antibiotiques de xk-62-2, leur procede de preparation et leur utilisation therapeutique
BE810427A (fr) Derives de xanthene et leur procede de preparation
BE818923A (fr) N-(2,4-dihalogeno-s-triazin-6-yl)-urees et leur procede de preparation
BE823873A (fr) Derives de benzopyranne et leur procede de preparation
BE801720A (fr) Derives de benzomorphane et leur procede de preparation
BE837605A (fr) Derives de 2-aminoacetamindo- -phenyllenzylidene aminoalcanols, leur procede de preparation et leurs applications en therapeutique

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: SANKYO CY LTD

Effective date: 19941126